The observation of bleeding complications in haemato-oncological patients: Stringent watching, relevant reporting

Transfusion Medicine

Volumn 22, Issue 6, 2012, Pages 426-431

  Ypma, P F ^a,b   Kerkhoffs, J L H ^a,b   van Hilten, J A ^b   Middelburg, R A ^b   Coccoris, M ^b   Zwaginga, J J ^b,c   Beckers, E M ^d   Fijnheer, R ^e   van der Meer, P F ^b   Brand, A ^b,c  

^a HAGA HOSPITAL   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

Bleeding; Hemato oncological patients; Platelet transfusion

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLEEDING; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; DEATH; DIGESTIVE SYSTEM HEMORRHAGE; DISEASE ASSOCIATION; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; OBSERVATIONAL STUDY; PILOT STUDY; PROSPECTIVE STUDY; RESPIRATORY TRACT HEMORRHAGE; SCORING SYSTEM; SKIN BLEEDING; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UROGENITAL TRACT DISEASE; WORLD HEALTH ORGANIZATION;

ADULT; AGED; FEMALE; HEMATOLOGIC NEOPLASMS; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET COUNT; PLATELET TRANSFUSION; PROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 84870253482     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2012.01193.x     Document Type: Article

References (31)

1. Blumberg, N., Heal, J.M. & Rowe, J.M. (2004) A randomised trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disorders, 4, 6.
2. Cook, R.J., Heddle, N.M., Rebulla, P., Sigouin, C.S. & Webert, K.E. (2004) Methods for the analysis of bleeding outcomes in randomised trials of PLT transfusion triggers. Transfusion, 44, 1135-1142.
3. 9 per L in allogeneic haematopoietic progenitor cell transplant recipients. Transfusion, 45, 1064-1072.
4. Friedmann, A.M., Sengul, H., Lehmann, H., Schwartz, C. & Goodman, S. (2002) Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A re-evaluation of prophylactic platelet transfusions. Transfusion Medicine Reviews, 16, 34-45.
5. Gil-Fernandez, J.J., Alegre, A., Fernandez-Villalta, M.J. et al. (1996) Clinical results of za stringent policy on prophylactic platelet transfusion: non-randomised comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplantation, 18, 931-935.
6. Gmur, J., Burger, J., Schanz, U., Fehr, J. & Schaffner, A. (1991) Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. The Lancet, 338, 1223-1226.
7. Heddle, N.M., Cook, R.J., Webert, K.E., Sigouin, C. & Rebulla, P. (2003) Methodo- logic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion, 43, 742-752.
8. Heddle, N.M., Cook, R.J., Tinmouth, A. et al. (2009) A randomised controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood, 113, 1564-1573.
9. Heddle, N.M., Arnold, D.M. & Webert, K.E. (2011) Time to rethink clinically important outcomes in platelet transfusion trials. Transfusion, 51, 430-434.
10. Higby, D.J., Cohen, E., Holland, J.F. & Sinks, L. (1974) The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion, 14, 440-446.
11. Kerkhoffs, J.-L.H., Eikenboom, J.C., Schipperus, M.R. et al. (2006) A multicenter randomised study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood, 108, 3210-3215.
12. Kerkhoffs, J.-L.H., van, Putten, W.L.J., Novotny, V.M.J. et al. (2010) Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. British Journal of Haematology, 150, 209-217.
13. Koreth, R., Weinert, C., Weisdorf, D.J. & Key, N.S. (2004) Measurement of bleeding severity: a critical review. Transfusion, 44, 605-617.
14. Lawrence, J.B., Yomtovian, R.A., Hammons, T., Masarik, S.R., Chongkolwatana, V., Creger, R.J., Manka, A. & Lazarus, H.M. (2001) Lowering the prophylactic platelet transfusion threshold: a prospective analysis. Leukemia & Lymphoma, 41, 67-76.
15. McCullough, J., Vesole, D.H., Benjamin, R.J. et al. (2004) Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial. Blood, 104, 1534-1541.
16. Miller, A.B., Hoogstraten, B., Staquet, M. & Winkler, A. (1981) Reporting results of cancer treatment. Cancer, 47, 207-214.
17. Murphy, S., Litwin, S., Herring, L.M., Koch, P., Remischovsky, J., Donaldson, M.H., Evans, A.E. & Gardner, F.H. (1982) Indications for platelet transfusion in children with acute leukemia. American Journal of Hematology, 12, 347-356.
18. Navarro, J.-T., Hernandez, J.-A., Ribera, J.-M., Sancho, J.-M., Oriol, A., Pujol, M., Milla, F. & Feliu, E. (1998) Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10, 000/μl versus 20, 000/μl. Haematologica, 83, 998-1000.
19. Nevo, S., Swan, V., Enger, C. et al. (1998) Acute bleeding after bone marrow transplantation (BMT) - incidence and effect on survival. A quantitative analysis in 1, 402 patients. Blood, 91, 1469-1477.
20. Oka, S., Muroi, K., Mori, M. et al. (2007) Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy. Internal Medicine, 46, 1669-1670.
21. Pihusch, R., Salat, C., Schmidt, E., Gohring, P., Pihusch, M., Hiller, E., Holler, E. & Kolb, H.-J. (2002) Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantion, 74, 1303-1309.
22. Rebulla, P., Finazzi, G., Marangoni, F. et al. (1997) The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. New England Journal of Medicine, 337, 1870-1875.
23. Sagmeister, M., Oec, L. & Gmur, J. (1999) A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anaemia. Blood, 93, 3124-3126.
24. Sensebe, L., Giraudeau, B., Bardiaux, L. et al. (2005) The efficiency of transfusing high doses of platelets in haematological patients with thrombocytopenia: results of a prospective, randomised, open, blinded end point (PROBE) study. Blood, 105, 862-864.
25. Slichter, S.J., Kaufman, R.M., Assmann, S.F., McCullough, J., Triulzi, D.J. & Strauss, R.G. (2010) Dose of prophylactic platelet transfusions and prevention of hemorrhage. New England Journal of Medicine, 362, 600-613.
26. The Mirasol Clinical Evaluation Study Group (2010) A randomised controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion, 50, 2362-2375.
27. Tinmouth, A., Tannock, I.F., Crump, M., Tomlinson, G., Brandwein, J., Minden, M. & Sutton, D. (2004) Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomised controlled trial with a sequential Bayesian design. Transfusion, 44, 1711-1719.
28. Vamvakas, E.C. (2011) Meta-analysis of the randomized controlled clinical trials of the hemostatic efficacy and capacity of pathogen-reduced platelets. Transfusion, 51, 1058-1071.
29. 9/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood, 91, 3601-3606.
30. Wandt, H., Schaefer-Eckart, K., Frank, M., Birkmann, J. & Wilhelm, M. (2006) A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 37, 387-392.
31. Zumberg, M.S., de, Rosario, M.L.U., Nejame, C.F., Pollock, B.H., Garzarella, L., Kao, K.J., Lottenberg, R. & Wingard, J.R. (2002) A prospective randomised trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10, 000/μl versus 20, 000/μl trigger. Biology of Blood and Marrow Transplantation, 8, 569-576.